Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Urinary Bladder, Neurogenic 1Urinary Bladder Neoplasms 1Urinary Bladder Diseases 1Small Cell Lung Carcinoma 1Pancreatic Neoplasms 1Malnutrition 1Head and Neck Neoplasms 1Esophagitis 1Endometriosis 1Cystitis, Interstitial 1Cystitis, Hemorrhagic 1Carcinoma, Hepatocellular 1

Interventions

pembrolizumab 25Cisplatin 17Carboplatin 13Radiotherapy 12Cetuximab 9Blood Specimen Collection 9Docetaxel 8Paclitaxel 7Fluorouracil 7Drug Therapy 7toripalimab 6tislelizumab 4nimotuzumab 4atezolizumab 4Radiation 4Chemoradiotherapy 4fludarabine 3Surveys and Questionnaires 3Surgical Procedures, Operative 3Standard of Care 3Radiotherapy, Intensity-Modulated 3Cyclophosphamide 3Biopsy 3130-nm albumin-bound paclitaxel 3cemiplimab 2avelumab 2X-Rays 2Tocopherols 2Tiragolumab 2Therapeutics 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Head and Neck Neoplasms × Immunonutrition Diet × Clear all
NCT04611113 2025-05-01

Immunonutrition and Tolerance to Chemoradiotherapy in Patients With Head-neck Cancer

Fondazione IRCCS Policlinico San Matteo di Pavia

Phase NA Recruiting
86 enrolled
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡